Pinazepam

Basic Information

Item Value
DrugBank ID DB13335
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 53

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 insomnia (disease) KG + DL
2 alcohol withdrawal delirium KG + DL
3 antidepressant type abuse KG + DL
4 hallucinogen abuse KG + DL
5 barbiturate abuse KG + DL
6 anxiety KG + DL
7 sleep disorder, initiating and maintaining sleep KG + DL
8 anxiety disorder KG + DL
9 alcohol withdrawal KG + DL
10 dysthymic disorder KG + DL
11 phencyclidine abuse KG + DL
12 benign paroxysmal torticollis of infancy KG + DL
13 agoraphobia KG + DL
14 Wernicke-Korsakoff syndrome KG + DL
15 acute encephalopathy with biphasic seizures and late reduced diffusion KG + DL
16 neurotic disorder KG + DL
17 alcohol-related disorders KG + DL
18 manic bipolar affective disorder KG + DL
19 restless legs syndrome KG + DL
20 vitamin B12-responsive methylmalonic acidemia KG + DL
21 neurotic depression KG + DL
22 irritable bowel syndrome KG + DL
23 melancholia KG + DL
24 drug dependence KG + DL
25 neurocirculatory asthenia KG + DL
26 Keppen-Lubinsky syndrome KG + DL
27 cauda equina syndrome KG + DL
28 autosomal dominant slowed nerve conduction velocity KG + DL
29 congenital isolated adrenocorticotropic hormone deficiency (disease) KG + DL
30 postpartum depression KG + DL
31 endogenous depression KG + DL
32 visual epilepsy KG + DL
33 epilepsy, childhood absence, susceptibility to KG + DL
34 Ohdo syndrome and variants KG + DL
35 early myoclonic encephalopathy KG + DL
36 myofascial pain syndrome KG + DL
37 mesial temporal lobe epilepsy with hippocampal sclerosis KG + DL
38 tendinitis KG + DL
39 mitochondrial membrane transport disorder KG + DL
40 blepharophimosis - intellectual disability syndrome, Ohdo type KG + DL
41 channelopathy-associated congenital insensitivity to pain, autosomal recessive KG + DL
42 myoclonus, familial KG + DL
43 neurohypophyseal diabetes insipidus KG + DL
44 neuralgia KG + DL
45 myositis fibrosa KG + DL
46 idiopathic granulomatous myositis KG + DL
47 migraine disorder KG + DL
48 startle epilepsy KG + DL
49 micturation-induced seizures KG + DL
50 orgasm-induced seizures KG + DL

(Showing top 50 of 53 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.